PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
Journal of Pathology and Translational Medicine. 2017;51(1):40-48 
Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
BMJ. 2018;k3529
2647 Prognostic significance of PD-L1 expression on tumor-infiltrating mononuclear cells in patients with urothelial carcinoma
European Journal of Cancer. 2015;51:S529
Detailed characterization of PD-1/PD-L1 and CTLA4 expression and tumor-infiltrating lymphocytes in yolk sac tumors
. 2022;
iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung Cancer
Cancers. 2020;12(11):3276
Dynamic Changes of Peripheral Blood Markers Predict Prognosis of Patients with Advanced Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 Treatment
. 2022;
Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes
Cancers. 2020;12(6):1386
Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients
Journal of the Egyptian National Cancer Institute. 2018;30(4):125-131
Clinical Significance of PD-L1 Expression and CD8-Positive Tumor-Infiltrating Lymphocytes in Patients with Cavitary Lung Adenocarcinoma
Oncologie. 2021;23(3):439-452
Beyond the Percentages of PD-L1-Positive Tumor Cells: Induced Versus Constitutive PD-L1 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma
Head and Neck Pathology. 2017;12(2):221-229